comparemela.com
Home
Live Updates
National Cancer Trial - Breaking News
Pages:
Latest Breaking News On - National cancer trial - Page 1 : comparemela.com
Molecularly Targeted Therapy May Improve Survival in Advanced, Recurrent Endometrial Cancer
Real-world data suggest that matched, targeted therapy may improve survival in patients with advanced or recurrent endometrial cancer.
North carolina
United states
Duke university medical center
Roche genentech
Angeles alvarez secord
Alvarez secord
Endometrial cancer molecularly targeted therapy consortium
National cancer trial network
Cancer therapy advisor
National cancer trial
vimarsana © 2020. All Rights Reserved.